Retractable Technologies (NYSE:RVP) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a report published on Tuesday. The firm issued a hold rating on the stock.

Retractable Technologies Stock Up 4.6 %

Shares of RVP stock opened at $0.63 on Tuesday. The stock’s 50 day simple moving average is $0.74 and its 200 day simple moving average is $0.95. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. Retractable Technologies has a twelve month low of $0.56 and a twelve month high of $1.34. The company has a market capitalization of $18.72 million, a price-to-earnings ratio of -1.16 and a beta of 2.06.

Insider Activity at Retractable Technologies

In related news, CEO Thomas J. Shaw acquired 71,422 shares of the business’s stock in a transaction that occurred on Friday, September 20th. The shares were acquired at an average cost of $0.82 per share, with a total value of $58,566.04. Following the purchase, the chief executive officer now owns 14,743,907 shares of the company’s stock, valued at approximately $12,090,003.74. The trade was a 0.49 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In the last ninety days, insiders have purchased 179,649 shares of company stock valued at $143,163. Corporate insiders own 55.00% of the company’s stock.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC purchased a new position in Retractable Technologies, Inc. (NYSE:RVP) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies as of its most recent SEC filing. Hedge funds and other institutional investors own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.